Taken together, our findings indicate a role for O‐GlcNAc modification in the dynamic, glucose‐induced impairment of endothelial nitric oxide synthase activation in endothelial cells from patients with T2DM. The gene discussed is NOS3; the disease is type 2 diabetes mellitus.